Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia
Author:
Affiliation:
1. Department I of Internal Medicine; University at Cologne; Cologne; Germany
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2012.01785.x/fullpdf
Reference39 articles.
1. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho);Kiyoi;Leukemia,1997
2. Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia;Schnittger;Leukemia,2011
3. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group;Abu-Duhier;Br J Haematol,2000
4. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials;Kottaridis;Blood,2001
5. FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype;Wagner;Haematologica,2011
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target;Aspects of Molecular Medicine;2023-12
2. FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia;Cancers;2022-08-19
3. FLT3-ITD Allele Frequency Is an Independent Prognostic Factor for Poor Outcome in FLT3-ITD–Positive AML Patients;Clinical Lymphoma Myeloma and Leukemia;2021-10
4. Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia;Clinics in Laboratory Medicine;2021-09
5. MRD Tailored Therapy in AML: What We Have Learned So Far;Frontiers in Oncology;2021-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3